Gabriela Placoná Diniz

Gabriela Placoná Diniz

Auto-generated profile, based on publicly available information

Gabriela Placoná Diniz


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2009 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
GDGabriela Placoná Diniz
Gabriela Placoná Diniz
MCMarcela Sorelli Carneiro-Ramos
Marcela Sorelli Carneiro-Ramos
MBMaria Luiza Morais Barreto-Chaves
Maria Luiza Morais Barreto-Chaves

13 June 2016
Verified
Book Chapter
Closed access
PDF file
GDGabriela Placoná Diniz
Gabriela Placoná Diniz
DWDa-Zhi Wang
Da-Zhi Wang

1 March 2010 in Vascular Pharmacology
Verified
Journal Article
Closed access
MBMaria Luiza M. Barreto-Chaves
Maria Luiza M. Barreto-Chaves
MCMaria Alícia Carrillo-Sepúlveda
Maria Alícia Carrillo-Sepúlveda
MCMarcela Sorelli Carneiro-Ramos
Marcela Sorelli Carneiro-Ramos
DGDayane A. Gomes
Dayane A. Gomes
GDGabriela P. Diniz
Gabriela P. Diniz

14 February 2010 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
MCMarcela Sorelli Carneiro-Ramos
Marcela Sorelli Carneiro-Ramos
GDG. P. Diniz
G. P. Diniz
ANA. P. Nadu
A. P. Nadu
JAJ. Almeida
J. Almeida
RVR. L. P. Vieira
R. L. P. Vieira
MBM. L. M. Barreto-Chaves
M. L. M. Barreto-Chaves

4 December 2017 in Clinical Science
Verified
Journal Article
Closed access
PDF file
GDGabriela Placoná Diniz
Gabriela Placoná Diniz
ZHZhan-Peng Huang
Zhan-Peng Huang
JLJianming Liu
Jianming Liu
JCJinghai Chen
Jinghai Chen
JDJian Ding
Jian Ding
DWDa-Zhi Wang
Da-Zhi Wang
Obesity is associated with development of diverse diseases, including cardiovascular diseases and dyslipidemia. MiRNA-22 (miR-22) is a critical regulator of cardiac function and targets genes involved in metabolic processes. Previously, we generated miR-22 null mice and we showed that loss of miR-22 blunted cardiac hypertrophy induced by mechanohormornal stress. In the present study, we examined the role of miR-22 in the cardiac and metabolic alterations promoted by high-fat (HF) diet. We found that loss of miR-22 attenuated the gain of fat mass and prevented dyslipidemia induced by HF diet, although the body weight gain, or glucose intolerance and insulin resistance did not seem to be affected. Mechanistically, loss of miR-22 attenuated the increased expression of genes involved in lipogenesis and inflammation mediated by HF diet. Similarly, we found that miR-22 mediates metabolic alterations and inflammation induced by obesity in the liver. However, loss of miR-22 did not appear to alter HF diet induced cardiac hypertrophy or fibrosis in the heart. Our study therefore establishes miR-22 as an important regulator of dyslipidemia and suggests it may serve as a potential candidate in the treatment of dyslipidemia associated with obesity.

10 February 2011 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
AAAlex Sander da Rosa Araujo
Alex Sander da Rosa Araujo
GDG.P. Diniz
G.P. Diniz
FSF.E.R. Seibel
F.E.R. Seibel
GBG. Branchini
G. Branchini
MRM.F.M. Ribeiro
M.F.M. Ribeiro
ABA. Belló-Klein
A. Belló-Klein